← Open Payments lookup

JORDAN MICHELENA: Open Payments

NPI 1396891057 · LOS ANGELES, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$566 in 20 payments from 11 companies in 2025. Trend: 2023 $523 · 2024 $258 · 2025 $566

Food & beverage: $416Speaker / faculty: $150
CompanyPaymentsAmount
Novo Nordisk Inc8$156
SANOFI-AVENTIS U.S. LLC1$150
Teva Pharmaceuticals USA, Inc.2$49
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)2$38
Indivior Inc.1$30
Otsuka America Pharmaceutical, Inc.1$29
Lilly USA, LLC1$27
Merck Sharp & Dohme LLC1$26
E.R. Squibb & Sons, L.L.C.1$21
Braeburn Inc.1$21

Products named: Wegovy, UZEDY, CAPLYTA, SUBLOCADE, REXULTI, MOUNJARO, ROTATEQ, COBENFY.

Industry payments across CA — which companies pay providers there.